Rifampin-Induced Severe Thrombocytopenia in a Patient with Pulmonary Tuberculosis

Girling DJ . Adverse reactions to rifampicin in antituberculosis regimens. J Antimicrob Chemother 1977; 3: 115–32.

Aquinas M Allan WGL Horsfall PAL Jenkins PK Wong HY Girling DJ . Adverse reaction to daily and intermittent rifampicin regimens for pulmonary tuberculosis in Hong Kong. Br Med J 1972; 1: 765–71.

Hadfield JW . Rifampicin-induced thrombocytopenia. Postgrad Med J 1980; 56: 59–60.

Cheng-Huei L Ching-Jyl L . A rare but potentially serious side effect of initial daily and interrupted use of rifampicin. Chest 1989; 96: 202–3.

Burnette PK Ameer B Hoang V Phifer W . Rifampin-associated thrombocytopenia secondary to poor compliance. DICP Ann Pharmacother 1989; 23: 382–4.

Pau AK Fisher MA . Severe thrombocytopenia associated with once-daily rifampin therapy. Drug Intell Clin Pharm 1987; 21: 882–4.

Guerra-Sanz FJ Rey-Durán R Martinez-Cuesta JJ Lara L Muñoz-Cabrera L Salama R Martinez-Riva P . A clinical approach to the short-term treatment of pulmonary tuberculosis. In: Rifampicin. A symposium held at the Forlanini Institute, Rome. Amsterdam: Excerpta Medica International Congress Series No. 437, 1977: 39–56.

Hong Kong Tuberculosis Treatment Services/Bropton Hospital/British Medical Research Council. Controlled trial of daily and intermittent rifampicin plus ethambutol in the retreatment of patients with tuberculosis: Results up to 30 months. Tubercle 1975; 56: 179–89.

Singapore Tuberculosis Service/British Medical Research Council. Controlled trial of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis in Singapore. Am Rev Respir Dis 1977; 116: 807–20.